Physician profile
David W Friedman
NPI 1043248495
$42,121.46
in general payments reported to CMS, 2019-2025
18 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what 79% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $6,011 · 2022: $128 · 2023: $305 · 2024: $1,196 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,803.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $38,663.67 | 2019-2022 | |
| Avita Medical Americas, LLC | $411.45 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Axogen | $397.45 | 2019-2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $365.84 | 2023-2024 | |
| Integra Lifesciences Corporation | $282.46 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $264.03 | 2019-2024 | Va-Lcp, Lcp |
| Abbvie INC. | $210.54 | 2024-2025 | |
| Polynovo North America LLC | $183.32 | 2025 | Novosorb Btm |
| Endo USA, INC. | $178.47 | 2024-2025 | Xiaflex |
| Tela Bio, INC. | $171.67 | 2024 | Ovitex 2s |
| Innovation Technologies INC | $170.15 | 2024 | Irrisept |
| Acumed LLC | $167.75 | 2025 | Acumed |
| Zimmer Biomet Holdings, INC. | $146.68 | 2024 | Dvr Anatomic Kickstand |
| Kerecis Limited | $145.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $144.32 | 2025 | Pico 14, Renasys Touch |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Coopersurgical, INC. | $96.01 | 2019 | |
| Bioventus LLC | $18.47 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.